SD Biosensor Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-63,218	-467,712	911,362	1,088,471	615,636	3,153
Depreciation & Amortization	148,782	137,541	40,820	19,115	7,974	4,331
Loss (Gain) From Sale of Assets	-4,431	1,045	1,804	1,373	580.55	56.06
Asset Writedown & Restructuring Costs	99,869	99,869	8,634	2,283	-	-
Loss (Gain) From Sale of Investments	-1,386	-4,046	-3,107	-9,480	-106.18	-1,094
Loss (Gain) on Equity Investments	3,405	986.91	2,560	-2,802	-5,978	1,248
Stock-Based Compensation	1,211	969.1	15,559	18,867	3,308	-
Provision & Write-off of Bad Debts	7,306	4,057	9,640	1,319	2,393	975.7
Other Operating Activities	-175,914	-164,296	-31,661	224,801	135,752	15.61
Change in Accounts Receivable	5,233	-5,177	62,516	185,970	-375,797	5,793
Change in Inventory	4,577	81,644	-28,604	35,418	-346,886	-10,644
Change in Accounts Payable	17,567	-31,006	-36,683	-304,205	428,503	-5,720
Change in Other Net Operating Assets	121,325	103,806	-63,831	-26,185	30,003	261.07
Operating Cash Flow	164,325	-242,319	889,008	1,234,945	495,382	-1,625
Operating Cash Flow Growth	341.50%	-	-28.01%	149.29%	-	-
Capital Expenditures	-88,587	-142,566	-301,999	-190,053	-54,904	-7,451
Sale of Property, Plant & Equipment	11,540	2,962	2,915	731.12	36	10.93
Cash Acquisitions	66,531	-1,748,595	-47,154	-36,764	-	-4,724
Sale (Purchase) of Intangibles	-1,434	-1,864	-3,248	-1,980	-245.41	-51.81
Investment in Securities	-178,425	-16,366	706,574	-901,853	-186,828	-23,000
Other Investing Activities	-2,660	-6,100	2,658	169,690	-3,183	-53.55
Investing Cash Flow	-192,351	-1,912,529	359,745	-960,569	-245,824	-35,233
Short-Term Debt Issued	-	-	81,679	-	12,815	17,000
Long-Term Debt Issued	-	835,483	-	-	-	2,039
Total Debt Issued	182,103	835,483	81,679	-	12,815	19,039
Short-Term Debt Repaid	-	-255,617	-81,695	-1,765	-22,374	-17,000
Long-Term Debt Repaid	-	-13,822	-11,623	-4,968	-3,606	-189.25
Total Debt Repaid	-127,184	-269,439	-93,319	-6,733	-25,980	-17,189
Net Debt Issued (Repaid)	54,918	566,044	-11,640	-6,733	-13,164	1,850
Issuance of Common Stock	1.08	227,604	2,383	507,472	-	49,349
Repurchase of Common Stock	-	-	-	-99,644	-	-
Dividends Paid	-	-29,550	-198,735	-49,831	-	-
Other Financing Activities	1,419	5,664	-17,745	2,839	-1,499	2,403
Financing Cash Flow	56,338	769,762	-225,737	354,102	-14,664	53,602
Foreign Exchange Rate Adjustments	58.75	-5,476	-31,665	9,899	-10,877	-210.08
Net Cash Flow	28,371	-1,390,561	991,351	638,377	224,016	16,533
Free Cash Flow	75,739	-384,884	587,008	1,044,892	440,478	-9,076
Free Cash Flow Growth	-	-	-43.82%	137.22%	-	-
Free Cash Flow Margin	11.24%	-58.70%	20.02%	35.66%	26.12%	-12.44%
Free Cash Flow Per Share	619.00	-3471.82	5794.81	10714.52	4710.19	-110.21
Cash Interest Paid	188,315	190,676	984.72	497.84	572.02	211.14
Cash Income Tax Paid	-	198,926	537,064	132,849	805.89	58.21
Levered Free Cash Flow	-104,651	-250,134	402,401	766,104	300,668	-
Unlevered Free Cash Flow	-63,302	-219,366	403,022	766,410	300,939	-
Change in Net Working Capital	81,979	58,158	60,570	-58,196	115,720	-

Source: S&P Capital IQ. Standard template. Financial Sources.